Title |
The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care
|
---|---|
Published in |
BMC Pulmonary Medicine, May 2014
|
DOI | 10.1186/1471-2466-14-88 |
Pubmed ID | |
Authors |
Jens Søndergaard, Anders Halling |
Abstract |
Chronic Obstructive Pulmonary Disease (COPD) is the most common severe chronic disease in primary care. It is typically diagnosed at a late stage, and it is also difficult to predict its trajectory and hence to tailor treatment and rehabilitation. The overall aim is to study determinants of exacerbations of COPD treated in primary care and to study, if the prognosis is related to patient-related, healthcare system markers or levels of the potential biomarkers such as microfibrillar-associated protein 4 (MFAP4) and surfactant protein D (SP-D). Furthermore, we aim to establish a cohort of COPD patients treated in Danish primary care comprising register data, data captured from the GPs' electronic patient record system (EPR) and a biobank in order to make analyses on factors associated with different tractories of COPD treated in primary care. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 3% |
Thailand | 1 | 1% |
Canada | 1 | 1% |
Unknown | 67 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 18% |
Student > Master | 12 | 17% |
Student > Ph. D. Student | 10 | 14% |
Student > Bachelor | 6 | 8% |
Other | 5 | 7% |
Other | 10 | 14% |
Unknown | 15 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 27% |
Nursing and Health Professions | 6 | 8% |
Biochemistry, Genetics and Molecular Biology | 5 | 7% |
Economics, Econometrics and Finance | 4 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 4% |
Other | 11 | 15% |
Unknown | 23 | 32% |